Risk factors for pneumonitis in solid tumors treated with anti-programmed death-1 therapy: A case-control study.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e15132
Abstract: e15132Background: Despite its great efficacy in patients with solid tumors, immune checkpoint blockade (ICB) might also lead to a series of inflammatory effects known as immune-related adverse even... read more here.
Keywords: solid tumors; factors pneumonitis; risk factors; treated anti ... See more keywords
Immune-induced pneumonia in patients with advanced solid tumors treated with immunotherapy: a real-world assessment.
Sign Up to like & getrecommendations! Published in 2023 at "Future oncology"
DOI: 10.2217/fon-2022-0826
Abstract: Aim: To investigate the computed tomography (CT) and clinical characteristics of immunotherapy-induced pneumonitis (IIP) in patients with advanced solid tumors. Patients & methods: CT and clinical data of 254 patients with advanced solid tumors treated… read more here.
Keywords: tumors treated; iip patients; patients advanced; immune induced ... See more keywords
Herpes zoster in patients with solid tumors treated with immune checkpoint inhibitors.
Sign Up to like & getrecommendations! Published in 2022 at "Immunotherapy"
DOI: 10.2217/imt-2021-0333
Abstract: Tweetable abstract Herpes zoster (HZ) is a vaccine-preventable disease, but the role of the vaccine in cancer patients during immunotherapy (ICIs) is still unknown. The clinical and economic consequences of HZ and the increased use… read more here.
Keywords: tumors treated; patients solid; treated immune; zoster patients ... See more keywords